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Objectives. This study sought to assess the incidence and 
consequences of abrupt closure in a series of patients undergoing 
directional coronary atherectomy versus percutaneous coronary 
angioplasty. 
Background. Abrupt closure with coronary angioplasty has 
been associated with adverse outcome. The results from the 
Coronary Angioplasty Versus Excisional Atherectomy Trial 
(CAVEAT) I, a randomized trial of coronary angioplasty versus 
directional coronary athereetomy, were analyzed. 
Method. This multicenter trial enrolled 1,012 patients from 
1991 to 1992. All records from patients with abrupt closure, which 
was coded as a discrete complication, were reviewed. 
Results. Abrupt closure occurred in 60 patients (5.9%) and was 
associated with a significantly longer hospital stay (median 8vs. 3 
days). Severe proximal target vessel tortnosity was more common 
in patients with abrupt closure (20.3% vs. 11.6%, p = 0.046), as 
was preexistent coronary artery thrombus (30.5% vs. 18.3%, p = 
0.02). Abrupt closure was associated with a marked increase in 
subsequent complications (myocardial infarction 46.7% vs. 2.1%, 
emergency b pass urgery 38.3% vs. 0.32%, death 33% vs. 0%) and 
occurred more frequently in the directional coronary atherectomy 
group (8.0% vs. 3.8%, p = 0.005). In the coronary angioplasty 
group, the occlusion usually occurred at the target lesion (91%), 
presumably related to the elects of barotrauma. In the directional 
coronary atherectomy group, the site of the occlusion was the 
target lesion in only 58% (p = 0.045). The remaining occlusions 
related to problems with the technique (guide catheter or nose 
cone trauma), reflecting the fact that directional coronary 
atherectomy is a more complex procedure. 
Conclusions. Abrupt closure remains the principal determinant 
of adverse outcome after percutaneous procedures for the treat- 
ment of coronary artery disease. Although abrupt closure is more 
common with directional atherectomy than angioplasty, the se- 
quelae are similar. 
(JAm Coll Cardiol 1995;26:1494-500) 
Abrupt or threatened closure remains the most serious proce- 
dural complication of percutaneous transluminal coronary 
angioplasty. The incidence of this complication has remained 
relatively constant over time, occurring in 2% to 10% of 
procedures (1-12). In prior series, it has been associated with 
a marked increase in the major clinical sequelae of acute 
infarction (40% to 50% of patients), need for emergency 
coronary bypass surgery (30% to 70% of patients) and mor- 
tality (5% to 7% of patients) (1-3,5,9). Early series of patients 
with abrupt or threatened closure were limited to conventional 
angioplasty procedures. There are limited, well controlled, 
prospectively collected ata on the incidence of this complica- 
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tion with newer interventional techniques such as directional 
coronary atherectomy (13,14). The purpose of the current 
study was to assess abrupt closure in the Coronary Angioplasty 
Versus Excisional Atherectomy Trial (CAVEAT) I and to 
evaluate its incidence, mechanisms and outcomes using each 
revascularization strategy. 
Methods  
The CAVEAT I trial design, methods and primary end 
point results have been previously published (15). Briefly, 35 
experienced centers randomized 1,012 patients with new native 
coronary artery lesions to undergo either coronary angioplasty 
or directional athereetomy from August 1991 to April 1992 
(15). The primary end point was angiographic 6-month resten- 
osis. All data were prospectively recorded at each site on case 
report forms and verified at the coordinating center at Duke 
University. To ensure data quality, the coordinating center 
audited all case report forms. In addition, arandom 15% of the 
forms were confirmed using the individual site's medical 
records. All cine angiograms for the trial were analyzed by 
blind assessment at the Cleveland Clinic Core Angiographic 
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Laboratory using quantitative coronary angiographic tech- 
niques. 
Both the case report forms and the angiographic ore 
laboratory evaluation included abrupt closure or coronary 
occlusion as a discrete complication for data entry and tabu- 
lation. For the present report, all records of patients with 
abrupt closure indicated either on the case report form or by 
the core angiographic laboratory were reviewed. In addition, 
all available angiographic films of abrupt closure were re- 
viewed by two operators (D.R.H. and J.S.) for angiographic 
and procedural details. There were 15 cases in which the case 
report form documented that occlusion had occurred, but 
either it was not documented on the cine angiographic film or 
the film was not available. 
Definitions. Abrupt closure was defined as Thrombolysis n 
Myocardial Infarction grade 0 or 1 flow in the target artery 
with clinical or electrocardiographic evidence of ischemia 
lasting >5 min that occurred after initiation of the procedure 
and before discharge from the hospital. 
Technical success was defined as a residual stenosis <-50% 
at the end of the procedure. Clinical success was defined as a 
residual stenosis -<50% and no major complication (death, 
myocardial infarction or emergency oronary bypass urgery). 
Myocardial infarction was diagnosed both clinically at each 
site and by an adjudication committee unaware of the treat- 
ment assignment. Infarction was defined as development of
new Q waves, elevation of creatine kinase (CK) isoenzyme 
levels to more than three times the upper limit of normal or 
elevation of CK levels to more than two times the upper limit 
of normal for the individual site's laboratory if no isoenzymes 
were obtained. 
Angiographic definitions are often imprecise. Dissection 
was considered to be present when there was contrast staining 
within the wall of the vessel. Contrast staining that occurred 
near the tip of the guiding catheter was judged to be guide 
catheter induced. If it occurred at the tip of the guide wire, it 
was judged to be related to the guide wire. If it occurred at the 
treated lesion, it was judged to be device related. Thrombus 
was considered present when there was an intraluminal fi ling 
defect or multiple defects, often with indistinct edges, or filling 
defects with contrast on each side. Finally, if occlusion oc- 
curred at the location of the tip of the atherectomy device, it 
was judged to be related to nose cone injury. 
Statistical analysis. Continuous data are expressed as me- 
dians with 25th and 75th percentiles unless otherwise indi- 
cated. Baseline clinical and angiographic haracteristics of 
each treatment group were compared by the chi-square test or 
Fisher exact test for categoric variables and Wilcoxon rank- 
sum test for continuous variables. 
Results 
Patients with abrupt closure. In this study of 1,012 pa- 
tients, abrupt closure was documented in 60 (5.9%). In 47 
patients (78%), the abrupt closure occurred in the catheter- 
ization laboratory during the initial protocol procedure, and 
Table 1. Baseline Clinical and Angiographic Characteristics of 
Patients With and Without Abrupt Closure 
No Abrupt 
Abrupt Closure Closure p 
(n = 60) (n - 952) Value 
Male gender 43 (71.7%) 692 (72.7%) 0.863 
Unstable angina 42 (70.0%) 648 (68.2%) 0.773 
MI within 14 days 17 (28.3%) 216 (22.7%) 0.314 
Diabetes mellitus 9 (15.0%) 182 (19.1%) 0.429 
Target vessel 
LMCA 0 (0.0%) 7 (0.75%) 
LAD 30 (50.8%) 533 (56.9%) 
Cx 10 (17.0%) 106 (11.3%) 
RCA 19 (32.2%) 290 (31.0%) 0.572 
Ejection fraction 60 (50, 65) 60 (50, 65) 0.681 
Vessels diseased 
1 37 (61.7%) 618 (65.0%) 0.637 
2 20 (33.3%) 280 (29.5%) 
3 3 (5.0%) 52 (5.5%) 
Data presented are number (%) of patients or median (25th, 75th percen- 
tiles). Cx = circumflex coronary artery; LAD = left anterior descending coronary, 
artery; LMCA = left main coronary artery; MI = myocardial infarction; RCA = 
right coronary artery. 
the remainder occurred after leaving the angiographic suite. 
There were no differences in baseline demographics of these 
patients with and without abrupt closure (Table 1). Specifi- 
cally, there was no difference in the frequency of unstable 
angina or myocardial infarction. Seventy percent of patients 
with abrupt closure had unstable angina compared with 68.2% 
of those without abrupt closure. 
There were few differences in lesion morphology between 
patients with and those without abrupt closure (Table 2). As 
can be seen, severe proximal target vessel tortuosity was more 
Table 2. Lesion Characteristics 
No Abrupt 
Abrupt Closure Closure p 
(n = 60) (n = 952) Value 
Length (ram) 9.1 (5.9, 12.9) 8.9 (6.5, 11.9) 0.895 
Diameter stenosis (%) 71.9 (61.5, 78.7) 72.1 (63.0, 78.2) 0.870 
MLD (mm) 0.79 (0.52, 1.06) 0.81 (0.61, 1.07) 0.785 
Calcification 27 (45.8%) 361 (38.8%) 0.286 
Eccentricity* 31 (52.5%) 513 (55.1%) 0.702 
Severe proximal 12 (20.3%) 108 (11.6%) 0.046 
tortuosity (%)t 
Preexistent lesion 18 (30.5%) 170 (18.3%) 0.020 
thrombus 
Severe angulation 8 (13.6%) 131 (14.1%) 0.913 
(_>45 ° )
Significant branch vessel 35 (59.3%) 595 (63.9%) 0.478 
involvement 
*->50% lesion asymmetrically positioned in one or more views, with one 
lumen edge within the vessel midline and the opposite lumen edge no more than 
one-half the distance between the normal edge and midline (16). tTwo or more 
60 ° bends in a vessel or at least one bend of 90 °. Data presented are number (%) 
of patients or median (25th, 75th percentiles). MLD = minimal luminal 
diameter. 
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Table 3. Comparison of Acute Outcomes 
Abrupt No Abrupt 
Closure Closure p 
(n = 60) (n = 952) Value 
Successful procedure 
(-<50% residual stenosis) 
Site 37 (64.9%) 930 (98.3%) <0.001 
Angio core lab 28 (70.0%) 773 (85.0%) 0.011 
Total MI 28 (46.7%) 20 (2.1%) <0.001 
Q wave MI 11 (18.3%) 4 (0.42%) <0.001 
Non-Q wave MI 17 (28.3%) 16 (1.7%) <0.001 
Emergency CABG 23 (38.3%) 3 (0.32%) <0.001 
Death 2 (3.3%) 0 0.003 
Length of stay (days) 8 (5.5, 10) 3 (3, 4) <0.001 
Data presented are number (%) of patients or median (25th, 75th percen- 
tiles). Angio core lab = angiographic core laboratory; CABG = coronary artery 
bypass graft surgery; MI = myocardial infarction. 
Table 4. Abrupt Closure During Directional Atherectomy 
Versus Angioplasty 
Directional 
Atherectomy Angioplasty p Value 
Abrupt closure 41 (8.0%) 19 (3.8%) 0.005 
During procedure 32 (78.0%) 15 (79.0%) 1.000 
After procedure 10 (24.4%) 4 (21.0%) 1.000 
Lesion location 
LAD 19 (46.3%) 11 (61.1%) 0.514 
RCA 15 (36.6%) 4 (22.2%) 
Cx 7 (17.1%) 3 (16.7%) 
Patency restored 25 (62.5%) 15 (83.3%) 0.137 
Emergency CABG 15 (36.6%) 8 (42.1%) 0.682 
Total MI (site) 19 (46.3%) 9 (47.4%) 0.941 
Q wave MI 8 (19.5%) 3 (15.8%) 1.000 
Non-Q wave MI 11 (26.8%) 6 (31.6%) 0.704 
Death 0 2 (10.5%) 0.097 
Data presented are number (%) of patients. Abbreviations as in Table 1. 
common in patients with abrupt closure (20.3% vs. 11.6%, p = 
0.046), as was angiographic evidence of pretreatment coronary 
artery thrombus (30.5% vs. 18.3%, p = 0.02). There were no 
other differences in lesion morphology between the two 
groups. 
Other complications. Abrupt closure was associated with a 
marked increase in the incidence of other complications (Table 
3). The only two deaths during the initial hospital period in the 
CAVEAT trial occurred in the abrupt closure group. Myocar- 
dial infarction rates were strikingly increased in patients with 
abrupt closure, occurring in 46.7% versus 2.1% of patients 
without abrupt closure (p < 0.001). Emergency bypass urgery 
was performed in 38.3% of patients with abrupt closure 
compared with 0.32% of the other patients (p < 0.001). The 
5.9% of patients who experienced abrupt closure, therefore, 
accounted for 57% of all infarctions in CAVEAT I and 88% of 
all emergency bypass graft surgery procedures. The length of 
stay of patients with abrupt closure was significantly increased. 
Clinical success was achieved in 9.1% of patients with abrupt 
closure compared with 62.7% of patients without abrupt 
closure (p < 0.001). 
Differences between treatment groups. The incidence of 
abrupt closure varied significantly in the two treatment arms. 
Treatment received was an independent predictor of abrupt 
closure. In the directional atherectomy group, abrupt closure 
occurred in 41 patients (8%) versus 19 in the coronary 
angioplasty group (3.8%) (p = 0.005). There was no difference 
in the timing of abrupt closure, which occurred during the 
initial procedure in 78% of the directional atherectomy group 
and 79% of the coronary angioplasty group (Table 4). The left 
anterior descending coronary artery was the most common 
artery treated in both groups, although in the directional 
coronary atherectomy abrupt closure group, there were more 
right coronary artery segments being treated than in the 
coronary angioplasty group. The numbers were small and did 
not reach statistical significance. Although abrupt closure 
occurred more frequently in the directional atherectomy 
group, once it had occurred in either group, there was no 
significant difference in clinical outcome. Patency was restored 
successfully in 62.5% of the directional coronary atherectomy 
group and 83.3% of the coronary angioplasty group (p = 
0.137). Usually, patency was restored with repeat coronary 
angioplasty (53.3%); stents were used infrequently (3.3%), and 
thrombolytic therapy was very uncommon (6.7%). The inci- 
dence of myocardial infarction or coronary bypass urgery after 
abrupt closure did not differ between the directional coronary 
atherectomy and coronary angioplasty groups. 
Characteristics of occlusions. The etiology and character- 
istics of abrupt closure were assessed inboth treatment groups 
(Table 5). In 44 patients, the original cine angiographic films 
documenting the occlusion were available for review. In 15 
patients there was either no cine angiographic documentation 
of abrupt occlusion or the cine film was not available. In these 
patients, the case report forms were used for assessment of
factors associated with occlusion (e.g., dissection or thrombus). 
The specific location and mechanism of occlusion, such as 
guide catheter trauma, were analyzed only in those patients in 
whom the angiogram was reviewed. 
The target artery was the vessel most commonly affected by 
Table 5. Mechanism of Occlusion* 
Directional 
Atherectomy Angioplasty p 
(n = 41) (n = 19) Value 
Target artery 36 (87.8%) 17 (89.5%) 0.781 
Occlusion-involved side branch 13 (31.7%) 7 (36.8%) 0.495 
Mechanism 
Dissection 28 (68.3%) 11 (57.9%) 0.518 
Thrombus 8 (19.5%) 4 (21.1%) 
Both 3 (7.3%) 1 (5.3%) 
Unknown 2 (4.9%) 3 (15.8%) 
*For this assessment, information from cine film review was used; in those 
patients in whom cine film documenting the abrupt closure was not available, the 
case report form and site physician assessment were used. Data presented are 
number (%) of patients. 
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Table 6. Location and Mechanism of Occlusion* 
Directional 
Atherectomy Angioplasty 
(n = 33) (n = 11) 
P 
Value 
Proximal to target lesion 10 (30.3%) 1 (9.1%) 
At target lesion 19 (57.6%) 10 (90.9%) 
Distal to target lesion 4 (12.1%) 0 (0%) 
Cause 
Guide catheter t auma 10 (30.3%) 1 (9.1%) 
Guide wire 2 (6.1%) 0 (0%) 
Nose cone injury 1 (3.0%) 0 (0%) 





*Assessed by review of cine angiographic details of occlusion. Data pre- 
sented are number (%) of patients. 
abrupt closure, although a side branch in the vicinity of the 
target lesion was involved in -33% of cases. The most 
common cause of the abrupt closure--dissection--was seen in 
68.3% of the directional coronary atherectomy group and 
57.9% of the coronary angioplasty group (p = 0.518). Throm- 
bus was the next most frequent cause and did not differ 
between the two groups. 
There were significant differences in the location of occlu- 
sion (Table 6). In the directional coronary atherectomy group, 
the location was proximal to the target lesion in 10 (30%), 
distal to the target lesion in 4 (12%) and at the lesion in 19 
(58%). In contrast, in the coronary angioplasty group abrupt 
closure occurred at the target lesion in 10 (91%). In the 
directional coronary atherectomy group, occlusions proximal 
to the target lesion were usually related to guide catheter 
trauma (Fig. 1), whereas lesions distal to the target lesion were 
secondary to either guide wire manipulation (Fig. 2) or nose 
cone trauma (Fig. 3). In patients treated by coronary angio- 
plasty, the cause of the occlusion was not apparent, and the 
balloon/artery atio appeared appropriate by visual estimate. 
The occlusion appeared to be related to the unpredictable 
nature of the barotrauma to the arterial segment dilated. 
Discussion 
Abrupt occlusion remains a major problem for interven- 
tional cardiology (1-12,17). Despite improvements in technol- 
ogy, increasing operator experience, more intensive heparin 
dosing and monitoring of activated clotting times, there has not 
been a major change in the incidence of periprocedural 
occlusion since the early days of interventional cardiology 
(1-3,5,8,9). In the most recent National Heart, Lung, and 
Blood Institute Percutaneous Transluminal Coronary Angio- 
plasty (1,2) Registry from 1985 to 1986, 6.8% of patients had a 
periprocedural occlusion. In the present report of 1,012 pa- 
tients from CAVEAT I with patient entry from 1991 to 1992, 
the incidence of abrupt closure was 5.9%. This is similar to 
other series over the past decade reporting on coronary 
angioplasty. In the past, abrupt closure has typically occurred 
in the angiographic laboratory (1-3,5,9). In the present series, 
~! :i i 
Figure 1. A, Left anterior oblique view of lesion to be treated in distal 
right coronary artery. B, Directional atherectomy was used. C, A 
dissection was found in the proximal right coronary artery beginning at 
the tip of the guiding catheter that propagated distally and occluded 
the vessel. 
78% of abrupt closures occurred in that setting, and only 22% 
occurred after patients left the laboratory. 
Characteristics ofincreased risk. Prior studies (3,8,9) have 
shown that certain baseline characteristics of patients are 
associated with increased risk of abrupt closure, particularly 
unstable angina, postinfarction angina and female gender. In 
the present series, there was no difference in these character- 
istics among patients with and without abrupt closure. The 
incidence of unstable angina was very high in each group (70% 
and 68%, respectively). 
Specific lesion and vessel characteristics have also been 
found (3,5,8,10,11,18-20) tobe associated with increased risk 
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Figure 2. A, Right anterior oblique view of left anterior descending 
coronary artery with a significant proximal stenosis. B, During atherec- 
tomy, the guide wire is looped in the mid-left anterior descending artery 
(arrow). C, After atherectomy, there is a dissection i  the mid-left 
anterior descending artery at the site of the looped guide wire (arrow). D, 
This localized issection results in occlusion of the mid-left anterior 
descending artery (arrow), seen in the left anterior oblique view. 
Figure 3. A, Cranial eft anterior oblique view of left main coronary 
artery documenting a severe eccentric proximal stenosis. B, During 
atherectomy, the guide wire is placed in the large diagonal branch. 
Nose cone is in the mid-left anterior descending coronary artery at the 
origin of the large diagonal branch. C, After atherectomy, the left 
anterior descending lesion has responded well, There is occlusion of 
the large diagonal branch at the site of the nose cone. 
of abrupt closure. Preexisting coronary artery thrombus re- 
mains an important risk factor despite the use of increasingly 
large doses of heparin and antiplatelet agents (11). Thirty 
percent of patients with abrupt closure had preexistent lesion 
thrombus compared with 18% of those without abrupt closure. 
The only other lesion characteristic associated with increased 
abrupt closure was proximal vessel tortuosity, which may be a 
particularly difficult problem for directional coronary atherec- 
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tomy. Other angiographic factors, including lesion eccentricity 
and angulation, were not associated with adverse outcome. 
Because of the inclusion criteria for this trial, however, some of 
these other adverse lesion characteristics were infrequent in 
patients considered for inclusion in CAVEAT I. In addition, 
patients with some lesion characteristics, uch as heavy calci- 
fication, which is associated with higher abrupt closure rates, 
were excluded from the trial. 
Outcomes after abrupt closure. Abrupt closure has been 
recognized as the most important risk factor for adverse 
hospital outcome using in-hospital mortality, myocardial in- 
farction and coronary bypass graft surgery as end points 
(2,3,5,9). These relations hold true for the present cohort. The 
only deaths during the initial hospital period in this trial 
occurred in patients with abrupt closure. Eighty-eight percent 
of all emergency coronary bypass urgical procedures and 57% 
of all myocardial infarctions also occurred in patients with 
abrupt closure. Although management strategies have changed 
(17,21-26), and perfusion balloons and other devices were 
widely available during this trial, they had little effect on 
outcome. In the entire trial, perfusion balloons were used in 
only 11% of patients, and stents or lasers in only 0.8%. In other 
series, stents have been shown (23-26) to decrease substan- 
tially the need for coronary bypass urgery and the frequency 
of acute myocardial infarction. 
Operator experience. The ability to restore patency in the 
present group of patients with abrupt closure (62.5% for 
directional atherectomy and 83.3% for coronary angioplasty) is 
somewhat improved compared with previous cohorts of pa- 
tients (2,3,7,9,12). This may be a result of the fact that for 
eligibility as an investigator, extensive interventional cardiol- 
ogy experience was required. Each operator had to have 
performed >400 dilation procedures and ->50 atherectomy 
procedures. Increasing operator experience with patients un- 
dergoing percutaneous revascularization procedures may be 
important in optimizing outcome, although even in the present 
experience with large vessels and usually proximal stenoses, 
only 60% to 80% of patients had patency restored at the end 
of the procedure. There was no difference between the direc- 
tional coronary atherectomy and coronary angioplasty groups 
in the incidence of myocardial infarction or coronary bypass 
surgery. 
Time course and etiology of abrupt closure. Although 
other studies (13,14,27-30) have reported complications with 
directional atherectomy versus coronary angioplasty, to our 
knowledge none has compared outcomes of therapy in the 
context of a randomized trial. In CAVEAT I, directional 
coronary atherectomy was associated with significantly in- 
creased abrupt closure compared with coronary angioplasty 
(8.0% vs. 3.8%, p < 0.005). The time course of occlusion was 
similar for both procedures. Once the occlusion had occurred, 
there was no significant difference in clinical outcome, which 
was characterized by increased rates of myocardial infarction, 
both Q wave and non-Q wave, and performance ofemergency 
coronary bypass urgery. 
The etiology of the abrupt closure was also similar between 
directional atherectomy and coronary angioplasty. As has been 
true with other series, dissection is the most common cause, 
followed by thrombus accumulation (5,8,10,20). Categoriza- 
tion of the etiology may be difficult because of the insensitivity 
of coronary angiography in documenting thrombus or small 
dissections. Irrespective of this problem, in the majority of 
patients with acute closure, an angiographically significant 
dissection appeared to play a dominant role. 
Although the etiology of the abrupt closure, that is, dissec- 
tion versus thrombus or a combination, was similar between 
directional atherectomy and coronary angioplasty, there were 
marked differences in specific patterns. With coronary angio- 
plasty, the occlusion usually occurred at the target lesion site 
even though an appropriately sized balloon had been used. 
This result is due to the unpredictable nature of the baro- 
trauma of balloon inflation. However, for directional atherec- 
tomy, the patterns were different and commonly reflected 
technical problems. Occlusion proximal to the target lesion was 
more common and often related to the large guide catheters 
required for the procedure. In addition, there were a small 
number of occlusions distal to the target lesion, either from 
nose cone injury or guide wire problems. The mechanisms of 
the etiology of the occlusion were, therefore, different between 
the two groups. The ability to restore flow after occlusion in the 
patients treated with directional coronary atherectomy was less 
than in patients treated with coronary angioplasty (62.5% vs. 
83.3%). This was not statistically significantly different because 
of the small numbers involved but may reflect problems 
dealing with complete occlusion occurring at a different site 
than the initial target lesion. 
Future developments. Significant advances in devices and 
adjunctive medical treatments will play an important role in 
the future treatment of patients with abrupt closure. Intracoro- 
nary stents have been shown (23-26) to significantly decrease 
complications of abrupt closure, but these were infrequently 
used in CAVEAT I. Newer antiplatelet regimens, specifically 
GPIIb/IIIa receptor blockers, may decrease ischemic compli- 
cations of percutaneous revascularization procedures. These 
drugs may be particularly advantageous in patients treated 
with directional coronary atherectomy. In the Evaluation of 
7E3 for Prevention of Ischemic Complications (EPIC) trial 
(31), patients treated with directional coronary atherectomy 
and a GPIIb/IIIa receptor-blocking drug had no increase in 
acute periprocedural infarction compared with patients treated 
with coronary angioplasty. This finding supports a distinct 
increased propensity of platelet hrombus as a mediator of 
complications with directional atherectomy. 
Conclusions. In this randomized trial of new coronary 
artery lesions treated with either directional coronary atherec- 
tomy or coronary angioplasty, the incidence of abrupt occlu- 
sion was similar to that reported in older series, reflecting the 
fact that this phenomenon remains a clinical problem despite 
technologic mprovements. When abrupt occlusion occurred, it
was associated with a marked increase in morbidity and length 
of stay. The 5.9% of patients with abrupt closure accounted for 
88% of emergency operations and 57% of the acute infarc- 
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tions. Abrupt closure occurred significantly more frequently in
patients randomized to directional coronary atherectomy 
(8.0% vs. 3.8%). Once the abrupt occlusion occurred, the 
clinical outcome was similar irrespective of which randomized 
group the patient was in. Finally, the pattern of occlusion 
differed between directional coronary atherectomy and coro- 
nary angioplasty; directional coronary atherectomy remains 
more complex to perform, and technical factors more often 
lead to complete occlusion than with coronary angioplasty, in
which the occlusion results from the unpredictable conse- 
quences of balloon inflation. 
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